comparemela.com

Latest Breaking News On - Institutional investors weigh in on rhythm pharmaceuticals - Page 1 : comparemela.com

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 8.2%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price rose 8.2% during mid-day trading on Monday . The company traded as high as $39.03 and last traded at $38.61. Approximately 174,823 shares were traded during trading, a decline of 71% from the average daily volume of 604,009 shares. The stock had previously closed at […]

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Rating Reaffirmed by Needham & Company LLC

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $50.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside […]

Rhythm Pharmaceuticals' (RYTM) "Buy" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities analysts also recently commented on RYTM. The Goldman Sachs Group upped their target […]

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52.00 at Wells Fargo & Company

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.